drugset / Trial / NCT00293540
Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer
Phase 3
Completed
249 enrolled
International Breast Cancer Research Foundation
Breast Cancer Research Foundation · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will determine if hormone receptor positive premenopausal metastatic breast cancer patients who undergo removal of the ovaries in mid-luteal versus mid-follicular phase have a longer survival.
Timeline
- Start
- 2006-02
- Primary completion
- 2014-02
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tamoxifen | Small molecule | 20 mg | Oral |